Cocrystal pharma selected to present at the world antiviral conference

Bothell, wa, nov. 10, 2020 (globe newswire) -- cocrystal pharma, inc. (nasdaq: cocp), (“cocrystal” or the “company”), a clinical stage biotechnology company discovering and developing novel antiviral therapeutics, today announced that dr. gary wilcox and dr. sam lee, have been selected to present at the world antiviral conference on thursday, november 12, 2020 at 1:20 pm est. the company's presentation titled, “antivirals against coronavirus and the a strains of the influenza virus,” will be accessible to those registered to attend the virtual event.
COCP Ratings Summary
COCP Quant Ranking